
Marksans Pharma shares jump over 8% after USFDA nod for lung infection treatment drug
In November last year, Marksans Pharma’s wholly-owned subsidiary received the USFDA’s final approval for for the over-the-counter Loperamide Hydrochloride Tablets USP, 2 mg.








